Search research articles
Contact Us
Filters
Showing results (211-220 of 422) with videos related to
Page
of 43
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 26, 2017
Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries
Patricia I Mathias, Barbara A MacKenzie, Christine A Toennis, et al.
Journal of Environmental Pathology and Toxicology
|
November 1, 1978
The influence of contaminants on the mutagenic activity of dibromochloropropane (DBCP)
R W Biles, T H Connor, N M Trieff, et al.
The Journal of Antimicrobial Chemotherapy
|
March 17, 2026
Global dissemination of optrA-mediated linezolid resistance in enterococci
Jia Qi Beh, Benjamin P Howden, Jessica R Webb, et al.
Human Pathology
|
October 1, 1984
Cardiac fungal infections: review of autopsy findings in 60 patients
J B Atkinson, D H Connor, M Robinowitz, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1978
Streptocerciasis: degeneration of adult Dipetalonema streptocerca in man following diethylcarbamazine therapy
W M Meyers, R Moris, R C Neafie, et al.
Pediatrics
|
June 1, 1974
Dermatophilus congolensis chronic nodular disease in man
R Albrecht, S Horowitz, E Gilbert, et al.
Molecular and Cellular Biology
|
September 21, 2001
Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1
J H Connor, D C Weiser, S Li, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 17, 2010
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
Paul J M Sessink, Thomas H Connor, James A Jorgenson, et al.
The Journal of Biological Chemistry
|
December 13, 2003
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases
Matthew H Brush, Amaris Guardiola, John H Connor, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 5, 2003
Update on the diabetic foot from Malvern foot conference 2002
C N Dang, Y D M Prasad, H Connor, et al.
Page
of 43
Search research articles
Search
Showing results (211-220 of 422) with videos related to
Sort By:
Page
of 43
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 26, 2017
Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries
Patricia I Mathias, Barbara A MacKenzie, Christine A Toennis, et al.
Journal of Environmental Pathology and Toxicology
|
November 1, 1978
The influence of contaminants on the mutagenic activity of dibromochloropropane (DBCP)
R W Biles, T H Connor, N M Trieff, et al.
The Journal of Antimicrobial Chemotherapy
|
March 17, 2026
Global dissemination of optrA-mediated linezolid resistance in enterococci
Jia Qi Beh, Benjamin P Howden, Jessica R Webb, et al.
Human Pathology
|
October 1, 1984
Cardiac fungal infections: review of autopsy findings in 60 patients
J B Atkinson, D H Connor, M Robinowitz, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1978
Streptocerciasis: degeneration of adult Dipetalonema streptocerca in man following diethylcarbamazine therapy
W M Meyers, R Moris, R C Neafie, et al.
Pediatrics
|
June 1, 1974
Dermatophilus congolensis chronic nodular disease in man
R Albrecht, S Horowitz, E Gilbert, et al.
Molecular and Cellular Biology
|
September 21, 2001
Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1
J H Connor, D C Weiser, S Li, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 17, 2010
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
Paul J M Sessink, Thomas H Connor, James A Jorgenson, et al.
The Journal of Biological Chemistry
|
December 13, 2003
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases
Matthew H Brush, Amaris Guardiola, John H Connor, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 5, 2003
Update on the diabetic foot from Malvern foot conference 2002
C N Dang, Y D M Prasad, H Connor, et al.
Page
of 43